Clinical Trial Update: Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the efficiency and safety of a pegylated form of somatropin for treating growth hormone deficiency in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Pegylated Somatropin (pegylated human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Growth Hormone Deficiency | Phase 2 | Status: COMPLETED